Tillmann, F.-P.; Figiel, L.; Ricken, J.; Still, H.; Korte, C.; Plassmann, G.; von Landenberg, P.
Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study. J. Clin. Med. 2021, 10, 5113.
https://doi.org/10.3390/jcm10215113
AMA Style
Tillmann F-P, Figiel L, Ricken J, Still H, Korte C, Plassmann G, von Landenberg P.
Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study. Journal of Clinical Medicine. 2021; 10(21):5113.
https://doi.org/10.3390/jcm10215113
Chicago/Turabian Style
Tillmann, Frank-Peter, Lars Figiel, Johannes Ricken, Hermann Still, Christoph Korte, Grete Plassmann, and Philipp von Landenberg.
2021. "Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study" Journal of Clinical Medicine 10, no. 21: 5113.
https://doi.org/10.3390/jcm10215113
APA Style
Tillmann, F.-P., Figiel, L., Ricken, J., Still, H., Korte, C., Plassmann, G., & von Landenberg, P.
(2021). Evolution of SARS-CoV-2-Neutralizing Antibodies after Two Standard Dose Vaccinations, Risk Factors for Non-Response and Effect of a Third Dose Booster Vaccination in Non-Responders on Hemodialysis: A Prospective Multi-Centre Cohort Study. Journal of Clinical Medicine, 10(21), 5113.
https://doi.org/10.3390/jcm10215113
